Why the "comprehensive designation" from the NCI matters
Related Resources
Clinical Trials
Breakthrough cancer treatments
Clinical trials offer patients access to breakthrough cancer treatments before they become widely available.
Cancer patients throughout the Sacramento region now have access to care judged to be among the best in the world. UC Davis Comprehensive Cancer Center’s unique, integrated cancer research programs, innovative biomedical technologies and cancer health disparities outreach and education have earned the prestigious “comprehensive” designation from the National Cancer Institute (NCI).
UC Davis Comprehensive Cancer Center is the only cancer center in Sacramento and all of inland Northern California to have earned the designation, the world’s most prestigious honor in oncology, reserved for less than 1 percent of cancer centers nationwide.
“Comprehensive” designation means patients get access to leading-edge treatments, including development of personalized therapies based on the unique molecular characteristics of individual patients’ tumors, and access to clinical trials in early phases of drug development. It also means that the physicians who see them in the clinics are working in concert with researchers to develop new approaches to detecting, preventing and beating cancer for all populations.
UC Davis Comprehensive Center is one of only 41 cancer centers in the United States designated “comprehensive” by the National Cancer Institute, including M.D. Anderson in Texas and Memorial Sloan-Kettering in New York.
Northern California
- UC Davis Comprehensive Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
Southern California
- UC Irvine Chao Family Comprehensive Cancer Center
- City of Hope Comprehensive Cancer Center
- UCLA Jonsson Comprehensive Cancer Center
- Moores Comprehensive Cancer Center
- USC Norris Comprehensive Cancer Center
Nationally
For a complete list go to: http://cancercenters.cancer.gov/documents/ccc_list.pdf.
